Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to <i>In Vivo</i> Pharmacodynamic Activity

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-20
DOI
https://doi.org/10.1021/acs.jmedchem.6c00004
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to In Vivo Pharmacodynamic Activity

J Liu, Yi Zou, Qinlong Xu, Qihua Zhu et al.
Journal of Medicinal Chemistry
PARP inhibition in cancer therapy
article

Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to In Vivo Pharmacodynamic Activity

J Liu, Yi Zou, Qinlong Xu, Qihua Zhu, Zhaoxing Chu, Shiqi Wu, Hongfeng Gu, Kaiyuan Cong, Ziyue Li, Guangwei He, Yan Zhao, Ping Wei, Shaoxue Lou, Xiangying Kong, Li Shao, Yungen Xu, Le Qu, Xiaorong Zeng
article en

Abstract

No abstract available for this paper.
Journal of Medicinal Chemistry
China Pharmaceutical University (CN), Hefei Design and Research Institute of Coal Industry (China) (CN), State Key Laboratory of Natural Medicine
Zero hunger
Openalex Percentile: Top 11%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.